Germany Dry Powdered Inhaler Market Size, Share, Trends & Forecast 2019-2025Posted by Avinash on February 18th, 2020 Germany dry powdered inhaler market is anticipated to grow at a substantial rate of around 3.7% during the forecast period. Germany is one of the key economies of the European region in terms of revenue generation and future opportunities for the dry powdered inhaler market. Major factors that augment the growth of the dry powdered inhaler market in the country include the significant prevalence of respiratory diseases such as asthma and COPD coupled with increasing geriatric population and growing focus towards the development of therapeutics to treat respiratory diseases. Request a Free Sample of our Report on Asia Germany Dry Powdered Inhaler Market : https://www.omrglobal.com/request-sample/germany-dry-powdered-inhaler-market According to the International Monetary Fund, in 2017, the population of the country was about 80 million and the share of the geriatric population is around 21%. Major companies working in the field of respiratory drug and device industry. Ingelheim based Boehringer Ingelheim International GmbH collaborated with Weill Cornell Medicine in February 2017. The collaboration aims to find new treatment approaches for chronic pulmonary diseases. The three-year collaboration aimed to develop novel treatments that could stop and decrease the progression of COPD. A full Report of Germany Dry Powdered Inhaler Market is Available at:https://www.omrglobal.com/industry-reports/germany-dry-powdered-inhaler-market Germany dry powdered inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators dry powdered inhalers are analyzed. The preventive dry powdered inhaler segment led the global dry powdered inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed. Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing dry powdered inhalers to cater to a wide range of customers within Germany and across the globe. The major players of the Germany Dry Powdered Inhaler market include Boehringer Ingelheim International GmbH, AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, Teva Pharmaceuticals Industries Ltd., Koninklijke Philips N.V., and many others. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players. Market Segmentation Germany Dry Powdered Inhaler Market by Type
Germany Dry Powdered Inhaler Market by Application
Germany Dry Powdered Inhaler Market by End-User
Company Profiles
About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Like it? Share it! More by this author |